Is CAPR up or down today?
CAPR is up 13.81% today, last at 8.24. This stock moved +13.81% versus the prior close.
CAPR · CAPR
CAPR (CAPR) is trading at 8.24, up 13.81% on the session. CAPR sits at the 14% mark of its 52-week range, carries a 14-day RSI of 59, and trades above its 50-day average. Over the past month it is down 7.93%.
Leading the coverage: “CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears” (Yahoo, 13d ago). CAPR is +5.95% since story.
CAPR trades on a trailing P/E of 45.6 and is running 5.94% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
CAPR is up 13.81% today, last at 8.24. This stock moved +13.81% versus the prior close.
Leading the coverage: “CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears” (Yahoo, 13d ago). CAPR is +5.95% since story. Dominant story: CAPR Stock Rises As Clinical Trial Investigators Write To FDA Urging Approval For Deramiocel - Stocktwits (2 sources, bullish) RSI is 59 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (124 days) · Drag or scroll left for earlier dates
CAPR Stock Rises As Clinical Trial Investigators Write To FDA Urging Approval For Deramiocel - Stocktwits
CAPR Stock Rises As Clinical Trial Investigators Write To FDA Urging Approval For Deramiocel
CAPR261030C00006000 Interactive Stock Chart | CAPR Oct 2026 6.000 call Stock - Yahoo Finance
Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
At 4:30 p.m. ET on Nov. 10, Capricor will host a results call. - Stock Titan